SouthState Corp’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Buy
175,072
+6,736
+4% +$539K 0.51% 57
2025
Q4
$16.1M Sell
168,336
-661
-0.4% -$64.8K 0.72% 42
2025
Q3
$16.5M Buy
168,997
+1,670
+1% +$173K 0.76% 39
2025
Q2
$18M Buy
167,327
+5,510
+3% +$558K 0.79% 36
2025
Q1
$16.3M Buy
161,817
+1,107
+0.7% +$111K 0.75% 39
2024
Q4
$14.4M Buy
160,710
+2,977
+2% +$262K 0.94% 30
2024
Q3
$13.2M Buy
157,733
+1,097
+0.7% +$86.5K 0.91% 35
2024
Q2
$12.1M Buy
156,636
+427
+0.3% +$31.3K 0.88% 34
2024
Q1
$10.7M Buy
156,209
+2,114
+1% +$136K 0.83% 38
2023
Q4
$8.91M Buy
154,095
+973
+0.6% +$51.9K 0.76% 41
2023
Q3
$8.08M Sell
153,122
-584
-0.4% -$30.6K 0.77% 42
2023
Q2
$8.31M Sell
153,706
-467
-0.3% -$24.4K 0.74% 42
2023
Q1
$7.71M Sell
154,173
-268
-0.2% -$12.6K 0.71% 44
2022
Q4
$7.15M Sell
154,441
-3,464
-2% -$150K 0.66% 47
2022
Q3
$6.12M Sell
157,905
-2,726
-2% -$109K 0.61% 51
2022
Q2
$5.99M Sell
160,631
-1,582
-1% -$64.4K 0.56% 50
2022
Q1
$7.18M Buy
162,213
+2,449
+2% +$106K 0.57% 54
2021
Q4
$6.79M Sell
159,764
-7,358
-4% -$309K 0.53% 56
2021
Q3
$7.25M Sell
167,122
-1,612
-1% -$71.3K 0.61% 52
2021
Q2
$7.21M Sell
168,734
-256
-0.2% -$10.8K 0.62% 50
2021
Q1
$6.53M Sell
168,990
-4,037
-2% -$153K 0.61% 47
2020
Q4
$6.22M Sell
173,027
-18,077
-9% -$652K 0.61% 45
2020
Q3
$7.3M Sell
191,104
-132
-0.1% -$5.09K 0.76% 44
2020
Q2
$6.71M Buy
191,236
+4,512
+2% +$162K 0.82% 38
2020
Q1
$6.09M Buy
186,724
+10,825
+6% +$423K 0.9% 33
2019
Q4
$7.95M Buy
175,899
+6,621
+4% +$277K 0.92% 33
2019
Q3
$6.89M Sell
169,278
-10,280
-6% -$436K 0.86% 38
2019
Q2
$7.72M Buy
179,558
+1,972
+1% +$75.8K 0.89% 37
2019
Q1
$6.82M Buy
177,586
+5,541
+3% +$212K 0.7% 50
2018
Q4
$6.08M Buy
172,045
+61,769
+56% +$2.24M 0.7% 54
2018
Q3
$4.25M Buy
+110,276
New +$3.85M 0.44% 78

Other funds holding BSX